Table. 4.
Overall activities of different antibiotics used against isolates
| Antibiotic | Resistance No. (%) | Sensitive No. (%) | Indeterminate No. (%) | MIC range |
|---|---|---|---|---|
| Amikacin | 17 (12.7) | 117 (87.3) | 0 | 4->32 |
| Amox/k clav | 76 (56.7) | 43 (32.1) | 15 (11.2) | ≤8/4->16/8 |
| Ampicillin | 89 (66.4) | 33 (24.6) | 12 (9) | ≤8->16 |
| Aztreonam | 53 (39.6) | 65 (48.5) | 16 (11.9) | ≤4->16 |
| Cefazolin | 111 (83.5) | 17 (12.8) | 5 (3.8) | ≤8->16 |
| Cefepime | 18 (13.4) | 112 (83.6) | 4 (3) | ≤2->16 |
| Cefotaxime | 40 (29.9) | 67 (50) | 27 (20.1) | ≤2->32 |
| Cefotaxime/k clav | 66 (49.3) | 53 (39.5) | 15 (11.2) | ≤0.5->4 |
| Cefoxitin | 92 (69.2) | 37 (27.8) | 4 (3) | ≤8->16 |
| Ceftazidime | 3 (2.2) | 126 (94) | 5 (3.7) | ≤1->16 |
| Ceftazidime/k clav | 47 (35.1) | 54 (40.3) | 33 (24.6) | ≤0.25->2 |
| Ceftriaxone | 37 (27.6) | 70 (52.2) | 27 (20.1) | ≤4->32 |
| Cefuroxime | 88 (66.2) | 40 (30.1) | 5 (3.8) | ≤4->16 |
| Ciprofloxacin | 5 (3.7) | 125 (93.3) | 4 (3) | ≤0.5->2 |
| Ertapenem | 32 (24.2) | 82 (62.1) | 18 (13.6) | ≤2->4 |
| Gentamicin | 14 (10.6) | 108 (81.8) | 10 (7.6) | ≤1->8 |
| Imipenem | 7 (5.2) | 121 (90.3) | 6 (4.5) | ≤1->8 |
| Levofloxacin | 1 (0.7) | 129 (96.3) | 4 (3.6) | ≤2->4 |
| Meropenem | 4 (3) | 123 (93.2) | 5 (3.8) | ≤1->8 |
| Piperacillin | 18 (13.7) | 109 (83.2) | 4 (3.1) | ≤16->64 |
| Pip/tazo | 10 (8.2) | 110 (90.2) | 2 (1.6) | ≤16->64 |
| Tetracycline | 26 (20.6) | 92 (73) | 8 (6.3) | ≤4->8 |
| Ticar/k clav | 45 (33.6) | 81 (60.4) | 8 (6) | ≤16->64 |
| Tobramycin | 10 (7.5) | 118 (88.7) | 5 (3.8) | ≤1->8 |
| Trimeth/sulpha | 53 (39.6) | 81 (60.4) | 0 | ≤2/38->2/38 |
| Amp/sulbactam | 0 | 2 (66.7) | 1 (33.3) | ≤8/4->16/8 |
Amox=Amoxicillin;
Amp=Ampicillin;
Clav=Clavulate;
MIC=Minimum inhibitory contentration;
Pip=Piperacillin;
Sulpha=Sulphamethoxasole;
Tazo: Tazobactam;
Ticar=Ticarcillin;
Trimeth=Trime-thoprim